EN ANNEX
3 ESA: ESMA, EIOPA and EBA Question ID: not available Regulation reference: Regulation (EU) 2019/2088 on sustainability‐related disclosures in the financial services Topic: sustainable finance disclosures Article: Article 4(3), Article 4(4), point (a) of Article 4(1) 1. Question As regards Article 4(4) of Regulation 2019/2088, must the calculation of the 500-employee threshold
Download EN ANNEX
Information
Domain:
Source:
Link to this page:
Documents from same domain
Public consultation on the governance of the Monitoring ...
www.esma.europa.euThe consultation paper rightly refers to International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) which is overseen by the Trustees of the IFRS Foundation and a Monitoring Board composed of public authorities.
Questions and Answers - ESMA
www.esma.europa.eu16 December 2016 | ESMA/2016/1669 Questions and Answers ... legislation or ESMA guidelines. 4. The European Commission has already published its own Q&A on AIFMD 6. II. Purpose ... part of a department) – can exert material influence on the AIFM’s risk profile or on an AIF it
Guidelines - ESMA
www.esma.europa.eu10 October 2016 | ESMA/2016/1452 Corrected on 07/08/2017 Guidelines Transaction reporting, order record keeping and clock synchronisation under MiFID II
Practical Guide - ESMA
www.esma.europa.euPractical Guide is intended as an aide to market participants and may be particularly helpful to shareholders with notification obligations under national law in …
Questions and Answers - ESMA
www.esma.europa.euApr 08, 2019 · 4 42. Rights issue: communication by a custodian to its clients in one member state about pre-emption rights in relation to a public offer of new shares taking place in another
Guidelines
www.esma.europa.eu5 application of Article 25(2) of MiFID II and of Articles 54 and 55 of the MiFID II Delegated Regulation. 10. ESMA expects these guidelines to promote greater convergence in the interpretation of,
Questions and Answers
www.esma.europa.euRegulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC ... European Commission adopted without modifications the regulatory technical standards developed by ... Directive 2004/39/EC of the European Parliament and the Council
Final Report
www.esma.europa.euproviders for business Regulation. 2 Date: 10 November 2021 . 3 Date: 10 November 2021 Table of Contents ... CA National competent authority or authorities designated by a Member State ... PRIIPS Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November 2014 on key information documents for ...
Guidelines on Liquidity Stress Testing in UCITS and AIFs
www.esma.europa.euThese Guidelines relate to liquidity stress testing in UCITS and AIFs. 3. In particular, in respect of managers they apply primarily in relation to Article 16(1) of the AIFMD, Articles 47 and 48 of the AIFMD Level 2 Regulation, Article 51 of the UCITS
BRIEFING Legal Entity Identifier (LEI) - Europa
www.esma.europa.euLegal Entity Identifier (LEI) The Legal Entity Identifier (LEI) is a 20-digit, alpha-numeric code that enables clear and unique identification of legal entities participating in financial transactions. 1 LEIs, like other identifiers, are needed by firms to fulfil their reporting obligations under financial regulations and directives.
Related documents
Irregular Warfare Annex to the National Defense Strategy ...
media.defense.govOct 02, 2020 · This summary of the Irregular Warfare Annex to the 2018 National Defense Strategy (NDS) provides a plan to institutionalize irregular warfare (IW) as an enduring core competency for the entire Joint Force. This plan is grounded in the lessons of recent conflict.
Acceptable Means of Compliance (AMC) and Guidance …
www.easa.europa.euConsolidated unofficial AMC/GM to Annex III (Part-ORO) Page 1 European Aviation Safety Agency . Acceptable Means of Compliance (AMC) and Guidance Material (GM) to . Annex III – Part-ORO . Consolidated version including Issue 2, Amendment 61. February 2016
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu3. PHARMACEUTICAL FORM Concentrate for dispersion for injection (sterile concentrate). The vaccine is a white to off-white frozen dispersion (pH: 6.9 -7.9). 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Comirnaty 30micrograms/dose concentrate for dispersion for injection is indicated for active
Performance Parameters - IPCC
www.ipcc.chthat occur during its lifetime (see formula in Annex II.3.1.1) as well as on the amount of energy that is provided by the respective technol-ogy. Cash flows are usually reported in some aggregate form based on widely deployed monetary accounting principles combining cash flows into different categories of expenditures and revenues that occur at
Annex 3 - WHO
www.who.intAnnex 3 . 121 . 1. Introduction. 1.1 Validation is an essential part of good practices, including good manufacturing practices (GMP) (6) and good clinical practices (GCP). It is therefore an element of the pharmaceutical quality system. Validation, as a concept, incorporates qualification and should be applied over the